Göktuna SI. IKBKE-driven TPL2 and MEK1 phosphorylations sustain constitutive ERK1/2 activation in tumor cells. EXCLI J. [Internet]. 2022 Feb. 18 [cited 2024 Apr. 24];21:436-53. Available from: https://www.excli.de/index.php/excli/article/view/4578